you are here: HomeNewsOpinion
Last Updated Last Updated : November 20, 2020 / 01:24 PM IST | Source:

Why can’t India’s start-up ecosystem produce a BioNtech or a Moderna?

The funding pattern in India's start-up ecosystem has been largely imitative and driven by quick returns. There has been little scope for impact investing which aims at the triple bottom line of people, planet and profits

Sundeep Khanna

To view the full content of this article, you have to be a Pro:

  • Already a Moneycontrol Pro subscriber?
  • Not a Moneycontrol Pro subscriber yet?

Subscribe to Moneycontrol Pro:

What's included:

  • Ad free experience across Platforms
  • 230+ exclusive stories per month
  • Sharpest Opinions & Actionable Insights
  • Exclusive Research & Expert Technical Analysis
  • Daily Newsletter
  • 20+ Technical Picks every week
  • Recovery Tracker
  • Exclusive webinars on varied topics
  • Weekly wrap up and much more!!!